%0 Journal Article
%T Glycemic variability is associated with subclinical atherosclerosis in Chinese type 2 diabetic patients
%A Yifei Mo
%A Jian Zhou
%A Mei Li
%A Yuwei Wang
%A Yuqian Bao
%A Xiaojing Ma
%A Ding Li
%A Wei Lu
%A Cheng Hu
%A Minghua Li
%A Weiping Jia
%J Cardiovascular Diabetology
%D 2013
%I BioMed Central
%R 10.1186/1475-2840-12-15
%X We conducted a cross-sectional study in 216 type 2 diabetic patients with a hemoglobin A1c of 8.3£¿¡À£¿1.7% and a median diabetes duration of 9.0 years. The standard deviation of blood glucose values (SDBG) and the mean amplitude of glycemic excursion (MAGE) were calculated from continuous glucose monitoring system data for assessing glycemic variability while 24h mean blood glucose (MBG) was calculated for measuring overall blood glucose level. Magnetic resonance angiography (MRA) was used to detect cervical and/or intracranial plaque, and ultrasonography was used to quantify carotid intima-media thickness (IMT) as an index of subclinical atherosclerosis.One hundred and fifty-three patients (70.8%) presented with cervical and/or intracranial lesions on MRA among 216 patients in the study. Elder age, increased systolic blood pressure, increased MBG and elevated low density lipoprotein cholesterol were independent contributors to plaque formation. In patients without stenosis (n£¿=£¿63), SDBG (r£¿=£¿0.412, P£¿=£¿0.001) and MAGE (r£¿=£¿0.365, P£¿=£¿0.005) were both correlated with carotid IMT and these relationships remained significant in multiple linear regression analysis (multiple R2£¿=£¿0.314 for the model including SDBG and multiple R2£¿=£¿0.268 for the model including MAGE). However, SDBG and MAGE were not significantly different among patients with different stenosis degrees.Glycemic variability is associated with subclinical atherosclerosis in Chinese type 2 diabetic patients.Macrovascular diseases such as coronary artery disease and cerebrovascular disease are major complications of type 2 diabetes. Previous studies have shown the association between averaged mean levels of glycemia and macrovascular complications [1,2]. Meanwhile, several lines of evidence have raised the possibility that glycemic variability, which includes both upward and downward acute glucose changes, is another important component of dysglycemia [3]. Glycemic variability can have deleterious effects on
%K Glycemic variability
%K Type 2 diabetes
%K Atherosclerosis
%K Intima-media thickness
%K Magnetic resonance angiography.
%U http://www.cardiab.com/content/12/1/15